ClinicalTrials.gg
Enrolling by invitationNCT07183670STEP-DoCUpdated Oct 28, 2026

A Speaking-Valve-Based Decannulation Protoco for Patients With a Prolonged Disorders of Consciousness

An observational study in Prolonged Disorders of Consciousness and Tracheostomy, sponsored by Hongying Jiang, MD. Enrolling by invitation at 2 sites in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-28.

Sponsored by Hongying Jiang, MD · Observational

How we know

Updated Oct 28, 2026Title changedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
184
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 70 studies in Consciousness Disorders with a site in China — 30 open to participants now, 31 under way, 1 of them phase 3. Consciousness Disorders · China.

Planned enrollment
12th of 30
184 · median 120
Started
2026
with 7 others
Observational
30 of 70
10 open now
Primary completion
2027-02
later than 21 of 30 live
Registered
61st of 70
by date
Lead sponsor
2 of 70
Hongying Jiang, MD

Among the 70 studies in Consciousness Disorders with a site in China, this one is the 12th largest by planned enrollment of the 30 observational ones that give a count, is one of 8 that started in 2026, is one of 30 observational ones, reaches primary completion later than 21 of the 30 other live ones, and was the 61st registered.

Consciousness Disorders

291 studies on the registry are indexed under Consciousness Disorders; 109 are open to participants now.

Browse Consciousness Disorders studies →

Open to participants now

30 of the 70 studies in Consciousness Disorders with a site in China are open now. Recruiting first, the newest first:

25 more — sign in →

All 30 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 74 Consciousness Disorders studies recruiting now, 31 (42%) set no upper age limit and 24 (32%) stop at 75 or younger; 12 take children under 18; 15 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 70 studies in Consciousness Disorders with a site in China, or all of them as a file.
02

Study summary

To evaluate the feasibility of a standardized tracheostomy decannulation protocol for patients with prolonged Disorders of Consciousness (pDoC) .

Read the detailed description

Advances in critical care have significantly increased the number of survivors with severe acquired brain injury (sABI). A subset of these patients develops Disorders of Consciousness (DoC), defined as prolonged DoC (pDoC) when lasting >28 days. Tracheostomy is often indicated for long-term mechanical ventilation and airway protection. However, tracheostomy tubes may cause inflammation, stenosis, excessive coughing, and dysphagia. Decannulation improves patient comfort, appearance, swallowing, communication, and social reintegration, while reducing long-term complications (e.g., tracheal stenosis, malacia, vocal cord injury, accidental decannulation) . Despite these benefits, consensus on safety and optimal timing for decannulation in pDoC remains elusive due to uncertain airway protection and aspiration risks. Our center previously demonstrated that a standardized decannulation protocol implemented by a pulmonary rehabilitation team correlates with successful decannulation. Key innovations include: (1) Replacing capping trials with 4-hour continuous tolerance of a speaking valve (reducing airway resistance and delayed decannulation ); (2) Not considering dysphagia a contraindication if patients manage secretions effectively and retain cough strength, even if requiring enteral nutrition (nasogastric/jejunal tubes or PEG) . This multicenter study aims to validate this protocol in pDoC patients and assess changes in consciousness levels pre-/post-decannulation.

03

Conditions studied

  • Prolonged Disorders of Consciousness
  • Tracheostomy

Keywords

  • Decannulation
  • Protocol
  • Rehabilitation
  • Prolonged disorders of consciousness
  • Speaking wave
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Condition: Prolonged Disorders of Consciousness (DOC >28 days) Population: Tracheostomized adults in hospitals

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Tracheostomy status
  2. The duration of consciousness disorders> 28 days
  3. CRS-R score >0 and \<17
  4. Signed by legal representative

Exclusion criteria

Exclusion Criteria:

  1. Non-PDOC tracheostomy patients
  2. Death within 2 weeks post-referral
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
184 participants (estimated)
Target follow-up
3 Months
Patient registry
Yes
Biospecimen retention
Samples without dna

Groups and cohorts

  • Decannulation Cohort

    Patients who pass decannulation protocol

    Diagnostic Test: decannulation protocol

  • Not-decannulation Cohort

    Patients failing at any protocol stage

    Diagnostic Test: decannulation protocol

Interventions

  • Diagnostic testdecannulation protocol

    Step 1: The patient's clinical stability is confirmed. Step 2: Tolerance to the speaking valve is assessed. Step 3: The wearing time of the speaking valve is extended continuously for 4 h, and no tracheostomy cannula is used for sputum suction within 4 h. Step 4: Cough strength is evaluated to be good before decannulation. Decannulation Criteria: Pass Step 1 + Step 2 + Step 3 + Step 4

06

What researchers measure

Primary outcomes

  1. Decannulation success rate

    (Decannulation - Decannulation failure ) / Total number of enrolled patients

    Time frame: At 48 hours post decannulation

Secondary outcomes

  1. Coma Recovery Scale-Revised (CRS-R) scores

    Comparison of CRS-R scores between the extubation group and the non-extubation group before extubation, A higher score (0-23) indicates better level of consciousness.

    Time frame: through study completion, an average of 1 year

  2. CRS-R change rate

    (Post-decannulation - Baseline)/Baseline

    Time frame: At a week post decannulation

  3. Time to decannulation

    Days from clinically stable to decannulation

    Time frame: through study completion, an average of 1 year

  4. Reintubation rate

    Unplanned reintubation

    Time frame: 90days follow-up

07

Study locations

2 sites
08

References and documents

Publications

  • Hakiki B, Draghi F, Pancani S, Portaccio E, Grippo A, Binazzi B, Tofani A, Scarpino M, Macchi C, Cecchi F. Decannulation After a Severe Acquired Brain Injury. Arch Phys Med Rehabil. 2020 Nov;101(11):1906-1913. doi: 10.1016/j.apmr.2020.05.004. Epub 2020 May 16. PubMed 32428445 ↗
  • Draghi F, Pancani S, De Nisco A, Romoli AM, Maccanti D, Burali R, Grippo A, Macchi C, Cecchi F, Hakiki B. Implications of the Consciousness State on Decannulation in Patients With a Prolonged Disorder of Consciousness. Arch Phys Med Rehabil. 2024 Sep;105(9):1691-1699. doi: 10.1016/j.apmr.2024.05.006. Epub 2024 May 10. PubMed 38734048 ↗
  • Zhou T, Wang J, Zhang C, Zhang B, Guo H, Yang B, Li Q, Ge J, Li Y, Niu G, Gao H, Jiang H. Tracheostomy decannulation protocol in patients with prolonged tracheostomy referred to a rehabilitation hospital: a prospective cohort study. J Intensive Care. 2022 Jul 16;10(1):34. doi: 10.1186/s40560-022-00626-3. PubMed 35842715 ↗

Individual participant data

Plan to share: No

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Feb 2027, 12 months after the start.

Of 57 non-industry observational studies under Consciousness Disorders, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 95. This study's planned 12 months is below that.

Counting every sponsor, half of 59 studies reached it within 40 months; a quarter within 22 and three quarters within 95.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 4, 2025
First posted
Sep 19, 2025
StartActual
Feb 1, 2026
Primary completionEst.
Feb 1, 2027
CompletionEst.
May 1, 2027
Last update
Oct 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Secondary outcomes
1 description edited
What changed in the outcomes
  • DescriptionTime to decannulation: how it is measured was reworded
Oct 19, 2026
Title
A Voice Speaking-Valve-Based Decannulation Protoco for Patients With a Prolonged Disorders of Consciousness
Oct 28, 2026
Show all 2 updates
  1. Oct 28, 2026
    Title A Voice Speaking-Valve-Based Decannulation Protoco for Patients With a Prolonged Disorders of Consciousness
  2. Oct 19, 2026
    Secondary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionTime to decannulation: how it is measured was reworded
    + 2 other changes: verification date and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07183670
Lead sponsor
Hongying Jiang, MD
Collaborators
Beijing Rehabilitation Hospital of Capital Medical University, Beijing Tiantan Hospital, Fengtai Rehabilitation Hospital of Beijing Municipality, People's Hospital of Zhengzhou University, Hunan Provincial Rehabilitation Hospital, Anhui Wanbei Rehabilitation Hospital, People's Hospital of Guangxi Zhuang Autonomous Region, The Second People's Hospital of Beihai
Responsible party
Hongying Jiang, MD (Principal Investigator, Capital Medical University) — Sponsor-investigator
First posted
Sep 19, 2025
Start date
Feb 1, 2026
Primary completion
Feb 1, 2027 (estimated)
Completion
May 1, 2027 (estimated)
Last update
Oct 28, 2026

Study contacts

Hongying Jiang
study chair · Beijing Rehabilitation Hospital, Capital Medical University, Beijing

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion